# Swati Spentose Private Limited – FDA Inspection, Dec 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/89f273ce-a3f8-4952-a9a9-976bc164c820
Source feed: FDA_Inspections

> FDA inspection 1076313 of Swati Spentose Private Limited, December 12, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1076313
- Company Name: Swati Spentose Private Limited
- Inspection Date: 2018-12-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1245668 - 2024-05-31
- [FDA Inspection 1037566 - 2018-01-12](https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/1dd87200-a2dc-4098-a73c-baa579e151c7)
- FDA Inspection 967302 - 2016-02-26

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)
- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)

Company: https://www.keypedia.com/companies/swati-spentose-private-limited/829926c8-b657-4a0d-ae81-83501694ede3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c